Wei Dong Liu

Director/Board Member en TOT BIOPHARM INTERNATIONAL COMPANY LIMITED .

56 años

Consumer Services

Health Technology

Health Services

Perfil

Wei Dong Liu is a non-executive director who currently holds two positions at Tot Biopharm Co. Ltd.
and TOT BIOPHARM International Co. Ltd.
He previously held a non-executive director position at Genetron Holdings Ltd.
Liu earned a doctorate degree from the University of Pittsburgh in 2000 and undergraduate and graduate degrees from Peking University in 1989 and 1994, respectively.

Cargos activos de Wei Dong Liu

Empresas	Cargo	Inicio
TOT BIOPHARM INTERNATIONAL COMPANY LIMITED	Director/Board Member	12/08/2023
Tot Biopharm Co. Ltd. Tot Biopharm Co. Ltd. Pharmaceuticals: MajorHealth Technology Tot Biopharm Co. Ltd. engages in research and development, manufacturing and sales of new drugs. The company was founded on July 5, 2010 and is headquartered in Suzhou, China.	Director/Board Member	12/08/2023

Todos los cargos activos de Wei Dong Liu

Antiguos cargos conocidos de Wei Dong Liu.

Empresas	Cargo	Fin
GENETRON HOLDINGS LIMITED	Director/Board Member	-

Ver el detalle de la experiencia de Wei Dong Liu.

Formación de Wei Dong Liu.

University of Pittsburgh	Doctorate Degree
Peking University	Graduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Wei Dong Liu.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
TOT BIOPHARM INTERNATIONAL COMPANY LIMITED	Health Technology

Empresas privadas	2
Tot Biopharm Co. Ltd. Tot Biopharm Co. Ltd. Pharmaceuticals: MajorHealth Technology Tot Biopharm Co. Ltd. engages in research and development, manufacturing and sales of new drugs. The company was founded on July 5, 2010 and is headquartered in Suzhou, China.	Health Technology
Genetron Holdings Ltd. Genetron Holdings Ltd. Medical/Nursing ServicesHealth Services Genetron Holdings, Ltd. engages in precision oncology. It provides cancer molecular profiling by using technologies in molecular biology and data science to transform cancer treatment. It products and services include diagnosis and monitoring through both LDT and IVD products. Its LDT portfolio consists of both specifically designed focused and comprehensive gene panel testing services. It also develops liver cancer early screening products. The company was founded by Si Zhen Wang, Hai Yan, and Wei Wu He in 2015 and is headquartered in Beijing, China.	Health Services